Annual cost of illness of stomach and esophageal cancer patients in urban and rural areas in China: A multi-center study
查看参考文献43篇
文摘
Objective: Stomach and esophageal cancer are imposing huge threats to the health of Chinese people whereas there were few studies on the financial burden of the two cancers. Methods: Costs per hospitalization of all patients with stomach or esophageal cancer discharged between September 2015 and August 2016 in seven cities/counties in China were collected, together with their demographic information and clinical details. Former patients in the same hospitals were sampled to collect information on annual direct non-medical cost, indirect costs and annual number of hospitalization. Annual direct medical cost was obtained by multiplying cost per hospitalization by annual number of hospitalization. Annual cost of illness (ACI) was obtained by adding the average value of annual direct medical cost, direct non-medical cost and indirect cost, stratified by sex, age, clinical stage, therapy and pathologic type in urban and rural areas. Costs per hospitalization were itemized into eight parts to calculate the proportion of each part. All costs were converted to 2016 US dollars (1 USD=6.6423 RMB). Results: Totally 19,986 cases were included, predominately male. Mean ages of stomach cancer and urban patients were lower than that of esophageal cancer and rural patients. ACI of stomach and esophageal cancer patients were $10,449 and $13,029 in urban areas, and $2,927 and $3,504 in rural areas, respectively. Greater ACI was associated with male, non-elderly patients as well as those who were in stage I and underwent surgeries. Western medicine fee took the largest proportion of cost per hospitalization. Conclusions: The ACI of stomach and esophageal cancer was tremendous and varied substantially among the population in China. Preferential policies of medical insurance should be designed to tackle with this burden and further reduce the health care inequalities.
来源
Chinese Journal of Cancer Research
,2018,30(4):439-448 【核心库】
DOI
10.21147/j.issn.1000-9604.2018.04.07
关键词
Cost of illness
;
stomach neoplasms
;
esophageal neoplasms
;
China
地址
1.
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center, National Clinical Research Center for Cancer, Beijing, 100021
2.
School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, 710061
3.
Henan Office for Cancer Control and Research, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450008
4.
Gansu Wuwei Tumor Hospital, Wuwei, 733000
5.
Cancer Epidemiology Research Center, Gansu Provincial Cancer Hospital, Lanzhou, 730050
6.
Linzhou Cancer Hospital, Linzhou, 456500
7.
Cixian Cancer Institute, Handan, 056500
8.
Luoshan Center for Disease Control and Prevention, Xinyang, 464299
9.
Center for Disease Control and Prevention of Sheyang County, Sheyang, 224300
10.
Heilongjiang Office for Cancer Control and Research, Harbin Medical University Cancer Hospital, Harbin, 150081
11.
Hunan Office for Cancer Control and Research, Hunan Cancer Hospital, Changsha, 410006
12.
Yueyang Lou District Center for Disease Prevention and Control, Yueyang, 414021
语种
英文
文献类型
研究性论文
ISSN
1000-9604
学科
肿瘤学
基金
supported by the Special Fund for Health Research in the Public Interest
文献收藏号
CSCD:6345433
参考文献 共
43
共3页
1.
Ervik M.
Cancer Today,2016
CSCD被引
2
次
2.
Chen W. Cancer statistics in China, 2015.
CA Cancer J Clin,2016,66:115-132
CSCD被引
4620
次
3.
Chen W. Cancer incidence and mortality in China, 2013.
Cancer Lett,2017,401:63-71
CSCD被引
102
次
4.
Guo L W. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).
Chin J Cancer,2017,36:73
CSCD被引
5
次
5.
Li X. Economic burden of gastrointestinal cancer under the protection of the New Rural Cooperative Medical Scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional survey.
Trop Med Int Health,2016,21:907-916
CSCD被引
4
次
6.
Zhao T. Inpatient care burden due to cancers in Anhui, China: a cross-sectional household survey.
BMC Public Health,2016,16:308
CSCD被引
2
次
7.
Agus A M. Description and predictors of hospital costs of oesophageal cancer during the first year following diagnosis in Northern Ireland.
Eur J Cancer Care (Engl),2013,22:450-458
CSCD被引
2
次
8.
Gordon L G. Healthcare resource use and medical costs for the management of oesophageal cancer.
Br J Surg,2011,98:1589-1598
CSCD被引
1
次
9.
de Oliveira C. Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study.
CMAJ Open,2013,1:E1-E8
CSCD被引
2
次
10.
Shin J Y. Costs during the first five years following cancer diagnosis in Korea.
Asian Pac J Cancer Prev,2012,13:3767-3772
CSCD被引
1
次
11.
Murata A. Endoscopic submucosal dissection for gastric cancer in elderly Japanese patients: an observational study of financial costs of treatment based on a national administrative database.
J Dig Dis,2014,15:62-70
CSCD被引
5
次
12.
Mariotto A B. Projections of the cost of cancer care in the United States: 2010-2020.
J Natl Cancer Inst,2011,103:117-128
CSCD被引
16
次
13.
Haga K. Cost of illness of the stomach cancer in Japan-a time trend and future projections.
BMC Health Serv Res,2013,13:283
CSCD被引
2
次
14.
Cai Y. Expenditure of hospital care on cancer in China, from 2011 to 2015.
Chin J Cancer Res,2017,29:253-262
CSCD被引
35
次
15.
Gbd 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.
Lancet,2017,390:231-266
CSCD被引
19
次
16.
Chen Z. Launch of the health-care reform plan in China.
Lancet,2009,373:1322-1324
CSCD被引
35
次
17.
Yip W C. Early appraisal of China's huge and complex health-care reforms.
Lancet,2012,379:833-842
CSCD被引
34
次
18.
Chen W. Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial.
Chin J Cancer Res,2017,29:294-302
CSCD被引
10
次
19.
He J.
Chinese cancer registry annual report, 2016,2017
CSCD被引
1
次
20.
Torre L A. Global cancer statistics, 2012.
CA Cancer J Clin,2015,65:87-108
CSCD被引
2236
次